Nuo Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Nuo Therapeutics, Inc. (AURX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum of 1.80% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum · last filed 2017-03-29
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2016 was 1.80%, a 28.57% increase from fiscal 2015.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2015 was 1.40%, a 1300.00% increase from fiscal 2014.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2014 was 0.10%, a 75.00% decline from fiscal 2013.
- Nuo Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, minimum for fiscal 2013 was 0.40%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 12 month |
|---|---|
| 2016-12-31 | 1.80% 10-K · filed 2017-03-29 |
| 2015-12-31 | 1.40% 10-K · filed 2017-03-29 |
| 2014-12-31 | 0.10% 10-K · filed 2015-03-31 |
| 2013-12-31 | 0.40% 10-K · filed 2015-03-31 |